23 March 2026
Austin, Texas, USA

The risk too many people are taking with Ozempic and other GLP-1s. - Slate

The risk too many people are taking with Ozempic and other GLP-1s. - Slate
Health

Listen to this article

0%

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily.
Every week, millions of Americans fill prescriptions for GLP-1 receptor a… [+8884 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

News Categories

Stay Connected